Your trusted source for investing success

Tag: GE

BioSig Technologies Provides Shareholder Update

BioSig Technologies Provides Shareholder Update

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today provided a shareholder update and highlighted the company’s recent achievements it has reached during the first part of

Lomiko Metals’ Graphene Files Supercapacitor Patent

Lomiko Metals’ Graphene Files Supercapacitor Patent

Graphene Energy Storage Devices Corp. (GESD), 40% owned by Lomiko Technologies, a 100% owned subsidiary of Lomiko Metals Inc. (TSXV:LMR,OTCQX:LMRMF,FSE:DH8B), is pleased to announce the successful completion of a development project undertaken jointly with the Research Foundation of Stony Brook University (SBU) has been completed with a new patent filing

BioSig Technologies Completes Private Placement

BioSig Technologies Completes Private Placement

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today announced the Company closed a private placement with proceeds of $4,349,953.50. Laidlaw & Co (UK) Ltd. in New

Lomiko and MegaHertz Sign Spider Distribution Deal

Lomiko and MegaHertz Sign Spider Distribution Deal

Lomiko Metals Inc. (TSXV:LMR,OTCQX:LMRMF,FSE:DH8B) has signed an agreement with engineering partners MegaHertz Power Systems Ltd. and SHD Smart Home Devices Ltd. to accelerate the launch of the USB Spider Charger. SHD is a company jointly launched by Lomiko and MegaHertz February 16, 2016, focused on Internet of Things (IoT)

BioSig Technologies Announces Strategic Partnership with Mayo Clinic

BioSig Technologies Announces Strategic Partnership with Mayo Clinic

BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today announced it has signed a ten-year strategic agreement with Mayo Clinic and Mayo Clinic Ventures. This new, expanded collaboration

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network